| 1 | 142217-69-4 | 恩替卡韦 | entecavir | C12H15N5O3
| 原料药;中间体;医药原料;抗病毒类;乙肝类药物;化学原料药;医药原料药;抗病毒药物;小分子抑制剂;抗病毒抗感染类 | |
| 2 | | 恩替卡韦-D4 | Entecavir-d2 | C12H15N5O3
| Bases & Related Reagents;Intermediates & Fine Chemicals;Isotope Labelled Compounds;Nucleotides;Pharmaceuticals | |
| 3 | | 1'-epi-Entecavir | 1'-epi-Entecavir | C12H15N5O3
| Anti-virals;Bases & Related Reagents;Chiral Reagents;Heterocycles;Impurities;Intermediates & Fine Chemicals;Nucleotides;Pharmaceuticals | |
| 4 | 1329796-53-3 | Entecavir-13C2,15N | Entecavir-13C2,15N | C12H15N5O3
| | |
| 5 | 1333204-94-6 | 恩替卡韦杂质 | Entecavir Impurity | C12H15N5O3
| 抗感染;杂质对照品 | |
| 6 | 1367369-79-6 | 恩替卡韦杂质SSR | (1S,3S,4R)-Entecavir | C12H15N5O3
| 恩替卡韦杂质 | |
| 7 | 138571-54-7 | 6'-C-methylneplanocin A | 6'-C-methylneplanocin A | C12H15N5O3
| | |
| 8 | 1367369-80-9 | 4-EPI-恩替卡韦 | (1'S,3'S,4'S)-Entecavir IsoMer | C12H15N5O3
| 杂质对照品;恩替卡韦杂质 | 恩替卡韦杂质;杂质对照品;Anti-virals, Chiral Reagents, Heterocycles, Impurities, Nucleotides, Bases & Related Reagents, Pharmaceuticals, Intermediates & Fine Chemicals;Anti-virals;Bases & Related Reagents;Chiral |
| 9 | 99901-16-3 | 8,2'-ethano-cyclo-2'-deoxyadenosine | 8,2'-ethano-cyclo-2'-deoxyadenosine | C12H15N5O3
| | |
| 10 | | 4-(4-NITRO-BENZOYL)-PIPERAZINE-1-CARBOXAMIDINE | 4-(4-NITRO-BENZOYL)-PIPERAZINE-1-CARBOXAMIDINE | C12H15N5O3
| | |
| 11 | | 9-(4-(1,2-dihydroxyethyl)-cyclopent-2-enyl)guanine | 9-(4-(1,2-dihydroxyethyl)-cyclopent-2-enyl)guanine | C12H15N5O3
| | |
| 12 | | 5-[(N-4-HYDROXY ETHOXY ETHYL)BENZAMIDYL]-1H-TETRAZOLE | 5-[(N-4-HYDROXY ETHOXY ETHYL)BENZAMIDYL]-1H-TETRAZOLE | C12H15N5O3
| | |
| 13 | | 2-Isopropyloxy-4-methoxy-N-(1H-tetrazol-5-yl)benzamide | 2-Isopropyloxy-4-methoxy-N-(1H-tetrazol-5-yl)benzamide | C12H15N5O3
| | |
| 14 | | 6-(2-Morpholin-4-yl-ethylamino)-5-nitro-nicotinonitrile | 6-(2-Morpholin-4-yl-ethylamino)-5-nitro-nicotinonitrile | C12H15N5O3
| | |
| 15 | 879071-96-2 | 2-(2-METHOXY-4-((1H-1,2,4-TRIAZOL-3-YLAMINO)METHYL)PHENOXY)ACETAMIDE | 2-(2-METHOXY-4-((1H-1,2,4-TRIAZOL-3-YLAMINO)METHYL)PHENOXY)ACETAMIDE | C12H15N5O3
| | |
| 16 | | 3-(1H-imidazol-4-yl)-2-[2-(1H-pyrazol-1-yl)propanamido]propanoic acid | 3-(1H-imidazol-4-yl)-2-[2-(1H-pyrazol-1-yl)propanamido]propanoic acid | C12H15N5O3
| | |
| 17 | | 7-Oxo-7H-1,2,3-triazolo[4,5-d]pyrimidine-5-carboxylic acid heptyl ester | 7-Oxo-7H-1,2,3-triazolo[4,5-d]pyrimidine-5-carboxylic acid heptyl ester | C12H15N5O3
| | |
| 18 | | 3-(1H-imidazol-4-yl)-2-{[3-(1H-imidazol-1-yl)propanoyl]amino}propanoic acid | 3-(1H-imidazol-4-yl)-2-{[3-(1H-imidazol-1-yl)propanoyl]amino}propanoic acid | C12H15N5O3
| | |
| 19 | | 3,9-dihydro-3-((2-hydroxyethoxy)methyl)-6-ethyl-9-oxo-5H-imidazo(1,2-a)purine | 3,9-dihydro-3-((2-hydroxyethoxy)methyl)-6-ethyl-9-oxo-5H-imidazo(1,2-a)purine | C12H15N5O3
| | |
| 20 | | 2-[(1,5-dimethyl-1H-pyrazol-4-yl)formamido]-3-(1H-imidazol-4-yl)propanoic acid | 2-[(1,5-dimethyl-1H-pyrazol-4-yl)formamido]-3-(1H-imidazol-4-yl)propanoic acid | C12H15N5O3
| | |
| 21 | 666207-37-0 | N-cyclopropyl-2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-9H-purin-9-yl)acetamide | N-cyclopropyl-2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-9H-purin-9-yl)acetamide | C12H15N5O3
| | |
| 22 | 113400-00-3 | 1H-Purine-2,6-dione, 7-acetyl-3,7-dihydro-1,3-dimethyl-8-(2-propenylamino)- (9CI) | 1H-Purine-2,6-dione, 7-acetyl-3,7-dihydro-1,3-dimethyl-8-(2-propenylamino)- (9CI) | C12H15N5O3
| | |
| 23 | 478078-47-6 | N-ETHYL-2-([3-(3-PYRIDINYL)-4,5-DIHYDRO-5-ISOXAZOLYL]CARBONYL)-1-HYDRAZINECARBOXAMIDE | N-ETHYL-2-([3-(3-PYRIDINYL)-4,5-DIHYDRO-5-ISOXAZOLYL]CARBONYL)-1-HYDRAZINECARBOXAMIDE | C12H15N5O3
| | |
| 24 | 100139-31-9 | 2-Quinazolinepropionic acid, 3-amino-3,4-dihydro-8-methoxy-4-oxo-, hydrazide (6CI) | 2-Quinazolinepropionic acid, 3-amino-3,4-dihydro-8-methoxy-4-oxo-, hydrazide (6CI) | C12H15N5O3
| | |
| 25 | | 5-({[2-(1H-IMIDAZOL-4-YL)ETHYL]AMINO}METHYLENE)-1,3-DIMETHYLPYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE | 5-({[2-(1H-IMIDAZOL-4-YL)ETHYL]AMINO}METHYLENE)-1,3-DIMETHYLPYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE | C12H15N5O3
| | |
| 26 | 1367369-77-4 | 恩替卡韦杂质SSS | 2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one | C12H15N5O3
| 恩替卡韦杂质 | |
| 27 | 1333204-93-5 | 恩替卡韦杂质09 | 2-amino-9-((1R,3R,4R)-4-hydroxy-3-(hydroxymethyl)-2-
methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one | C12H15N5O3
| | |
| 28 | 188399-46-4 | 2-氨基-1,9-二氢-9-[(1R,3S,4R)-4-羟基-3-(羟基甲基)-2-亚甲基环戊基]-6H-嘌呤-6-酮 | 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]- | C12H15N5O3
| 抑制剂;医药中间体;杂质对照品;恩替卡韦杂质 | 恩替卡韦杂质;医药中间体;抑制剂;杂质对照品 |
| 29 | 1367369-78-5 | 恩替卡韦杂质RRS | 2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate | C12H15N5O3
| 杂质对照品;恩替卡韦杂质;对照品-杂质对照品 | 恩替卡韦杂质;对照品-杂质对照品;杂质对照品 |
| 30 | 174498-00-1 | Bicyclo[3.1.0]?hexane-?2,?3-?diol, 4-?(6-?amino-?9H-?purin-?9-?yl)?-?1-?(hydroxymethyl)?-?, (1R,?2R,?3S,?4R,?5S)? | Bicyclo[3.1.0]?hexane-?2,?3-?diol, 4-?(6-?amino-?9H-?purin-?9-?yl)?-?1-?(hydroxymethyl)?-?, (1R,?2R,?3S,?4R,?5S)? | C12H15N5O3
| | |
| 31 | 267642-30-8 | Bicyclo[3.1.0]?hexane-?2,?3-?diol, 1-?(6-?amino-?9H-?purin-?9-?yl)?-?4-?(hydroxymethyl)?-?, (1R,?2S,?3R,?4R,?5S)?- | Bicyclo[3.1.0]?hexane-?2,?3-?diol, 1-?(6-?amino-?9H-?purin-?9-?yl)?-?4-?(hydroxymethyl)?-?, (1R,?2S,?3R,?4R,?5S)?- | C12H15N5O3
| | |
| 32 | 72496-59-4 | 4-amino-9-[[[(1S,4S,5R)-4,5-dihydroxy-1-cyclopent-2-enyl]amino]methyl]-3,5,7-triazabicyclo[4.3.0]nona-3,8,10-trien-2-one | 4-amino-9-[[[(1S,4S,5R)-4,5-dihydroxy-1-cyclopent-2-enyl]amino]methyl]-3,5,7-triazabicyclo[4.3.0]nona-3,8,10-trien-2-one | C12H15N5O3
| | |